Summary

MINERVA NEUROSCIENCES

Description

Minerva Neurosciences is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of product candidates to treat patients suffering from central nervous system (CNS) diseases. Their product portfolio in...

Strengths

  • MINERVA NEUROSCIENCES has a strong market share in their industry
  • Since MINERVA NEUROSCIENCES was founded, the company has grown faster than the industry average

Weaknesses

  • Revenue generated per employee is less than the industry average

Annual Revenue

MINERVA NEUROSCIENCES's annual revenue

$1903000

Based on Kona Equity data

  • Revenue per employee

    $211444

  • Annual revenue growth since founding

    $126867

Employee Count

9 employees

Executives

Jay Saoud

Senior VP Head of Research & Development

j**@minervaneurosciences.com

Joseph Reilly

Senior VP & Chief Operating Officer

j**@minervaneurosciences.com

William Boni

Corporate Communications Vice President, Investor Relations

w**@minervaneurosciences.com

Remy Luthringer

President & Chief Executive Officer

r**@minervaneurosciences.com

Andre Richer

Vice President, Program Management

a**@minervaneurosciences.com

Phone Neurosciences

President & Chief Executive Officer

p**@minervaneurosciences.com

Frederick Ahlholm

Senior Vice President and Chief Accounting Officer

f**@minervaneurosciences.com

Anthony Aliquo

Assistant Controller

a**@minervaneurosciences.com

Geoff Race

President

g**@minervaneurosciences.com

Iulia Dimitrova

Sub-investigator

i**@minervaneurosciences.com

G Score - 2

The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.

  • G1 Revenue is greater than the industry median.
  • G6 Annual revenue growth since founding is higher than the industry average.

Location

1601 Trapelo Rd Ste 286 
Waltham, MA  02451

Unlock unlimited leads

Get access to millions of contacts, companies, emails, and more!

Similar Companies

NeurOp

neuropinc.com
  • Founded in 2001
  • Location: Atlanta, GA
  • Annual Revenue: $977.0K
  • Employees: 5
  • NeurOp, Inc. is a clinical stage biotechnology company developing medicines for pain, stroke, subarachnoid hemorrhage, and treatment-resistant depression. Our compounds target various subunits of N methyl D aspartate (NMDA) receptors in the central ner...

TorreyPines Therapeutics

torreypinestherapeutics.com
  • Founded in 2015
  • Location: La Jolla, CA
  • Annual Revenue: $13.4M
  • Employees: 60
  • Business intelligence on pharmaceutical and biologic drugs - life cycle management, brand erosion, generic entry, biosimilars, 505(b)(2), patents, sales, litigation, and more...

vTv Therapeutics Inc.

vtvtherapeutics.com
  • Founded in 2015
  • Location: High Point, NC
  • Annual Revenue: $5.0M
  • Employees: 9
  • Committed to Improving the Lives of Patients with Diabetes vTv is a clinical-stage biotechnology company with a pipeline of drug candidates led by TTP399, a potentially transformative treatment for the reduction of hypoglycemic episodes in type 1 diabe...

Soligenix Inc

soligenix.com
  • Founded in 1987
  • Location: Princeton, NJ
  • Annual Revenue: $859.0K
  • Employees: 13
  • Soligenix is a late-stage biopharmaceutical company that develops and commercializes products that treat rare diseases.

TRACON Pharmaceuticals

traconpharma.com
  • Founded in 2004
  • Location: San Diego, CA
  • Annual Revenue: $346.0K
  • Employees: 19
  • TRACON Pharmaceuticals is a biopharmaceutical company focused on developing targeted therapies for cancer and macular degeneration. They utilize a cost-efficient, contract research organization (CRO) independent product development platform to partner ...

Monopar Therapeutics Inc

monopartx.com
  • Founded in 2015
  • Location: Wilmette, IL
  • Annual Revenue: $3.0M
  • Employees: 9
  • Monopar Therapeutics Inc. is a clinical stage biopharmaceutical company primarily focused on developing proprietary therapeutics designed to extend life or improve the quality of life for cancer patients. Their pipeline includes Validive for the preve...

Key Information

  • SIC: 28; 283
Disclaimer: These numbers are estimates and any other company information is based off our proprietary algorithms and by no means should be accepted as 100% factual. Kona Equity is in no way affiliated with MINERVA NEUROSCIENCES.

See similar companies

Frequently Asked Questions

Where is MINERVA NEUROSCIENCES located?

MINERVA NEUROSCIENCES's headquarters are located at 1601 Trapelo Rd Ste 286  Waltham, MA  02451.


What is MINERVA NEUROSCIENCES's official website?

MINERVA NEUROSCIENCES's official website is minervaneurosciences.com


What is MINERVA NEUROSCIENCES's revenue?

MINERVA NEUROSCIENCES's annual revenue is $1.9 M.


What is MINERVA NEUROSCIENCES's SIC code?

MINERVA NEUROSCIENCES's SIC: 28; 283


How many employees does MINERVA NEUROSCIENCES's have?

MINERVA NEUROSCIENCES has 9 employees


What industry does MINERVA NEUROSCIENCES belong to?

MINERVA NEUROSCIENCES is in the industry of Pharmaceuticals.

Next step

Visitors review